Table 1 In-depth interview guide – perceptions of ATIs and partner protections among racial, ethnic, sex and gender diverse HIV serodifferent partners in the United States (United States, 2020 – 2021)

Introduction

  • First, thank you so much for your time in completing today’s couples’ interview.

  • Are you both in a safe and comfortable place where you both are able to actively participate for the full duration of today’s discussion?

Interview Questions

  • Can you please describe your experiences with current HIV medications?

  • Have you heard of the expression U = U (Undetectable = Untransmittable)?

  • What are your thoughts about analytical treatment interruptions used in HIV cure-related studies?

  • How does your understanding of U = U fit within the context of an HIV cure-related study with an ATI?

  • Do you think safety provisions should be put in place to protect partners throughout your participation on an HIV cure-related study?

  • Do you think it would be beneficial to offer pre-exposure prophylaxis (PrEP) to sexual partners of participants enrolled in HIV cure-related research trials during treatment interruption phase of the study?

  • Should anything else besides PrEP be offered to either the study participants or their partners? If so, what should be offered?

  • Would you consult your partner if you had to make a decision about whether to participate in an HIV cure-related research?